|
UBE2G2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.882400E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.297630E-01 |
| Normal-vs-Stage2 |
3.778600E-03 |
| Normal-vs-Stage3 |
1.606050E-02 |
| Normal-vs-Stage4 |
5.59929999999209E-05 |
| Stage1-vs-Stage2 |
3.360400E-02 |
| Stage1-vs-Stage3 |
1.545430E-01 |
| Stage1-vs-Stage4 |
5.227300E-04 |
| Stage2-vs-Stage3 |
4.023400E-01 |
| Stage2-vs-Stage4 |
4.920000E-01 |
| Stage3-vs-Stage4 |
7.834100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.340400E-03 |
| Normal-vs-AfricanAmerican |
7.294200E-02 |
| Normal-vs-Asian |
6.088400E-01 |
| Caucasian-vs-AfricanAmerican |
7.967200E-01 |
| Caucasian-vs-Asian |
6.428000E-01 |
| AfricanAmerican-vs-Asian |
7.194600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.575000E-04 |
| Normal-vs-Female |
4.550600E-01 |
| Male-vs-Female |
1.178070E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.040000E-03 |
| Normal-vs-Age(41-60Yrs) |
1.552060E-02 |
| Normal-vs-Age(61-80Yrs) |
1.430340E-02 |
| Normal-vs-Age(81-100Yrs) |
6.861200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.059800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.386980E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.409360E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.660000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.220200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.898600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.163000E-01 |
| Normal-vs-Grade 2 |
3.415600E-01 |
| Normal-vs-Grade 3 |
1.302310E-03 |
| Normal-vs-Grade 4 |
2.13539999999179E-05 |
| Grade 1-vs-Grade 2 |
2.972100E-02 |
| Grade 1-vs-Grade 3 |
2.018900E-04 |
| Grade 1-vs-Grade 4 |
4.41669999995398E-06 |
| Grade 2-vs-Grade 3 |
1.643420E-03 |
| Grade 2-vs-Grade 4 |
8.07210000000058E-05 |
| Grade 3-vs-Grade 4 |
9.815500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.132600E-01 |
| Normal-vs-ccB subtype |
2.168000E-04 |
| ccA subtype-vs-ccB subtype |
4.30399999999942E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.337000E-03 |
| Normal-vs-N1 |
1.251710E-02 |
| N0-vs-N1 |
2.982800E-01 |
|
|
